Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.

Andreas R GantenbeinChristophe BonvinChristian P KammChristoph J SchankinChiara ZeccaDominik ZieglgänsbergerGabriele Susanne Merki-FeldHeiko PohlNicole RudolphPhilippe RyvlinReto AgostiElisabeth SchäferIna MeyerMonika Kulartz-SchankMichael E Arzt

Published in: Journal of neurology (2024)

Treatment interruption was associated with a temporary worsening of condition, which improved again after therapy restart.

Keyphrases

multiple sclerosis
stem cells
bone marrow
cell therapy
drug induced